Context: Short-chain fatty acids (SCFAs) have been reported to be associated with the
pathogenesis of irritable bowel syndrome (IBS), but the results are conflicting. Objective …

Diet is a cornerstone in the management of irritable bowel syndrome (IBS). There is
evidence of efficacy across the spectrum of dietary management strategies, including some …

A diet with low content of fermentable oligo-, di-, and monosaccharides and polyols
(FODMAP) is established treatment for irritable bowel syndrome (IBS), with well-documented …

Background Abdominal pain can be an overlooked symptom in patients with ulcerative
colitis (UC). Aims The aim of this study was to investigate the prevalence and factors …

Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction that impacts a
significant portion of the population and is associated with substantial morbidity, reduced …

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized
by chronic or recurrent gastrointestinal symptoms without organic changes, and it is also a …

Introduction: Irritable bowel syndrome (IBS) is a common condition that alters the quality of
life of patients. A variety of dietary interventions have been introduced to address this …

Background & Aims Limiting the dietary intake of certain carbohydrates has therapeutic
effects in some but not all irritable bowel syndrome (IBS) patients. We investigated genetic …

Background Diet plays an important role in management of gastrointestinal (GI) symptoms in
patients with irritable bowel syndrome (IBS). Restrictive diets have gained popularity as …

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory
process. Although by definition, a diagnosis of IBS cannot be made, the prevalence of 'IBS in …